Entrada Therapeutics, Inc. (TRDA): Price and Financial Metrics
TRDA Price/Volume Stats
| Current price | $6.55 | 52-week high | $21.79 |
| Prev. close | $6.76 | 52-week low | $6.48 |
| Day low | $6.48 | Volume | 220,000 |
| Day high | $6.84 | Avg. volume | 136,138 |
| 50-day MA | $7.79 | Dividend yield | N/A |
| 200-day MA | $12.78 | Market Cap | 248.59M |
TRDA Stock Price Chart Interactive Chart >
Entrada Therapeutics, Inc. (TRDA) Company Bio
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy. It also engages in the development of EEV-PMO for the treatment of Duchenne myotonic dystrophy type 1 (DM1). The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
TRDA Price Returns
| 1-mo | -16.56% |
| 3-mo | -17.09% |
| 6-mo | -51.01% |
| 1-year | -61.81% |
| 3-year | -36.04% |
| 5-year | N/A |
| YTD | -62.12% |
| 2024 | 14.58% |
| 2023 | 11.61% |
| 2022 | -21.03% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...